_20241026134003_original_image_49.webp)
At the 9th edition of CAHOTECH 2024, Karnataka's Minister for Health & Family Welfare, Dinesh Gundu Rao, delivered a forward-looking address, emphasising the potential of technology in healthcare.
Read More (1)_20241026114433_original_image_43.webp)
At the 9th edition of CAHOTECH, Dr. Devi Shetty, founder of Narayana Health, shared insights into the two-decade journey of building their digital healthcare platform, Athma.
Read More_20241026105321_original_image_48.webp)
The 9th edition of CAHOTECH, at the J.N. Tata Auditorium in Bangalore, brought together leaders and innovators from healthcare and technology sectors. The theme, "Redefining Healthcare: Technology as the Catalyst for Change," sets the stage for a day of insightful discussions aimed at accelerating innovation in healthcare.
Read More_20241025114052_original_image_2.webp)
The CAHO Masterclass for Startups, taking place on 25 October 2024 at the J.N. Tata Auditorium, will provide a comprehensive roadmap for healthcare entrepreneurs looking to bring their innovations to market.
Read More_20241025111505_original_image_9.webp)
The CAHOTECH 2024 Pitch Fest, happening today, promises to be an exciting platform for healthcare startups and innovators to present their groundbreaking solutions.
Read More
Corneal blindness is rising sharply in India, with an estimated 20,000 to 25,000 new cases annually. This adds to the existing 12 lakh cases, making corneal blindness one of the major contributors to vision loss, accounting for 7.5 per cent of the total blindness burden in the country.
Read More
The UK’s Medicines and Healthcare products Regulatory Agency has approved Eli Lilly's new treatment for early-stage Alzheimer’s disease, donanemab, marketed under the brand name Kisunla.
Read More
HCG announced the launch of outpatient (OPD) consultations in Goa, expanding access to specialised cancer treatments for local patients. In collaboration with local hospitals.
Read More
Fortis Hospital Bannerghatta Road successfully treated a 16-year-old boy from Africa suffering from severe aplastic anaemia, a life-threatening condition where the bone marrow fails to produce sufficient blood cells.
Read More
Niva Bupa Health Insurance, backed by private equity firm True North (formerly Max Bupa), has received final approval from the Securities and Exchange Board of India (SEBI) to raise Rs 3,000 crore through an initial public offering (IPO).
Read More
